Renowned biologist Craig Venter, instrumental in decoding the human genome and advancing synthetic biology, has passed away.

According to the J. Craig Venter Institute, Venter died “after a brief hospitalization due to unexpected side effects from treatment for a recently diagnosed cancer.” He was 79 years old.

Venter’s legacy is vast and impactful, marked by significant advancements in genomics and biodiversity. His career also highlighted the commercialization of biological research and the competitive nature of modern science.

Venter’s journey into research was unconventional; after high school, he was an uninterested student drawn to sailing and surfing. His experience in the US Navy during the Vietnam War inspired him to turn his life around. Upon returning home, he pursued higher education, eventually becoming a biomedical researcher at the National Institutes of Health (NIH) in the 1980s.

Venter’s fascination with the human genome led him to utilize automated sequencing machines, significantly accelerating research. He began with sequencing short DNA fragments called expressed sequence tags, igniting controversy when he claimed NIH would patent these sequences, leading to heated debates within the scientific community.

The Official Human Genome Project (HGP) launched in 1990, but Venter deemed their methods too slow. In 1998, he founded the for-profit company Celera Genomics to expedite the sequence, competing against the publicly funded HGP.

While HGP employed Sanger sequencing, which involved mapping and piecing together the genome, Venter introduced the shotgun sequencing technique. This novel method involved breaking the genome into random pieces followed by sequencing and computer analysis. In 1995, he successfully sequenced the whole bacterial genome, laying the groundwork for targeting the more complex human genome.

The race culminated in a draw, with both teams publishing draft sequences in 2000, followed by their finalized results the next year. The HGP released all of its data publicly, while Venter’s Celera initially withheld some for commercial benefit.

Despite backlash from the genetic community, Venter moved forward with his innovative research. From 2004 to 2006, he sailed aboard his yacht, the Sorcerer II, collecting seawater samples and sequencing vast amounts of DNA, resulting in the identification of over 1000 new protein families.

Venter’s ambition extended to creating synthetic life forms, asserting that manipulating organisms could yield significant advantages in fields ranging from medicine to agriculture. In 2010, his team synthesized a novel cell.

Starting with the bacterium Mycoplasma mycoides, they synthesized an artificial genome by combining lab-generated DNA strands and replaced the original genome with an artificial one, allowing the cell to thrive and multiply instead of dying.

Venter clarified that he did not create life from scratch but engaged in generating a new form of life whose genome was entirely computer-generated, lacking biological ancestry. His team humorously inscribed their names onto the genome, symbolizing the successful transfer of genetic data.

Venter faced skepticism from fellow synthetic biologists who questioned the purpose of his flashy experiments, suggesting that alternative approaches may yield more practical outcomes. However, he persisted in refining his work, stripping away non-essential genes to develop organisms with “minimal genomes,” revealing many unknown essential gene functions and underscoring the complexity of life.

It will take extensive analysis for historians to evaluate Venter’s full impact on science. Nevertheless, his contributions are undeniably profound and transformative.